Research map: Genomic surveillance and evolutionary dynamics of SARS-CoV-2 variants in Yunnan, China, 2022–2025

Back to the article

Papers in this map

  1. Nextstrain: real-time tracking of pathogen evolution · James N. Hadfield · 2018 · 3516 citations · Cited by this paper
  2. Systematic optimization of a domestic nose-only aerosol exposure system for respiratory pathogen research in nonhuman primates · 2026 · Related
  3. The effect of human mobility and control measures on the COVID-19 epidemic in China · Moritz U. G. Kraemer · 2020 · 3125 citations · Cited by this paper
  4. The holistic rehabilitation from acute severe fever with thrombocytopenia syndrome virus infection to 10 years after recovery: A cross-sectional study · 2025 · Related
  5. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study · Qifang Bi · 2020 · 2020 citations · Cited by this paper
  6. Predict SARS-CoV-2 genome interactions based on RNA language models · 2025 · Related
  7. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa · Raquel Pricilla e Silva Viana · 2022 · 1926 citations · Cited by this paper
  8. Application progress and biosafety challenges of gene editing and synthetic biotechnology in diagnosis, treatment and prevention of infectious diseases · 2025 · Related
  9. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity · Qianqian Li · 2020 · 1644 citations · Cited by this paper
  10. Establishment and application of a rapid and visual detection method for Mycoplasma pneumoniae using enzymatic recombinase amplification combined with lateral flow dipstick · 2026 · Related
  11. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization · Delphine Planas · 2021 · 1625 citations · Cited by this paper
  12. The PABS system under the pandemic agreement: Current status, controversies in negotiations, and future trends · 2026 · Related
  13. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection · Yunlong Cao · 2022 · 1461 citations · Cited by this paper
  14. An improved and high-throughput mpox virus microneutralization assay · 2026 · Related
  15. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 · Lihong Liu · 2021 · 1455 citations · Cited by this paper
  16. SFTS exerts an underrecognized disease burden and socioeconomic effect in East Asia · 2025 · Related
  17. Tree Visualization By One Table (tvBOT): a web application for visualizing, modifying and annotating phylogenetic trees · Jianmin Xie · 2023 · 1369 citations · Cited by this paper
  18. Interactions between zoonotic pathogens and infectious disease spread: Why understanding mechanisms and modelling matters more than ever · 2025 · Related
  19. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies · Allison J. Greaney · 2021 · 1321 citations · Cited by this paper
  20. Harnessing a high-quality Salmonella genome catalog to combat antimicrobial resistance and inform outbreak responses · 2025 · Related
  21. Global Transport Networks and Infectious Disease Spread · Andrew J. Tatem · 2006 · 657 citations · Cited by this paper
  22. Tracking virus outbreaks in the twenty-first century · Nathan D. Grubaugh · 2018 · 560 citations · Cited by this paper
  23. Virological characteristics of the SARS-CoV-2 JN.1 variant · Yu Kaku · 2024 · 334 citations · Cited by this paper
  24. Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China · Jing Lu · 2020 · 299 citations · Cited by this paper
  25. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase · Joseph A. Newman · 2021 · 261 citations · Cited by this paper
  26. Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2 · Philippe Lemey · 2020 · 188 citations · Cited by this paper
  27. Public health actions to control new SARS-CoV-2 variants · Nathan D. Grubaugh · 2021 · 185 citations · Cited by this paper
  28. An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain · Allison J. Greaney · 2022 · 173 citations · Cited by this paper
  29. Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 · Fanchong Jian · 2024 · 154 citations · Cited by this paper
  30. Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75 · Qian Wang · 2022 · 123 citations · Cited by this paper
  31. Upper respiratory tract and otolaryngological manifestations of coronavirus disease 2019 (COVID-19): A systemic review · Jamil N. Al-Swiahb · 2021 · 18 citations · Cited by this paper
  32. Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3 · Yanping Hu · 2025 · 11 citations · Cited by this paper
  33. Genetic diversity and evolutionary dynamics of the Omicron variant of SARS-CoV-2 in Morocco · Safae El Mazouri · 2023 · 9 citations · Cited by this paper
  34. Characterization of eight novel full-length genomes of SARS-CoV-2 among imported COVID-19 cases from abroad in Yunnan, China · Yuanyuan Jia · 2020 · 7 citations · Cited by this paper
  35. Receptor binding mechanism and immune evasion capacity of SARS-CoV-2 BQ.1.1 lineage · Chenghai Wang · 2024 · 3 citations · Cited by this paper
  36. Recombination Events Among SARS-CoV-2 Omicron Subvariants: Impact on Spike Interaction With ACE2 Receptor and Neutralizing Antibodies · Marwa Arbi · 2024 · 2 citations · Cited by this paper
  37. Validation of an MLV-based SARS-CoV-2 pseudovirus neutralization assay substantiates L455S-mediated antibody escape · Dominik Moll · 2026 · 2 citations · Cited by this paper
  38. Age, sex and seasonal differences in COVID-19 viral load: a Lebanese cross-sectional study · Elie Charro · 2025 · 1 citation · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)